MG Flashcards
danger zone ?
med/inf FG tx. where ca hide
where does most BCA start
TDLU
MCL of ectopic Br tx
axilla
2nd: infamammary fold
modality of choice in pregnant or lactating lady ?
US
dense Br»_space; low MG Sn
MCL of galactocele?
subareoloar
lactating adenoma
- look like FA
- estrogen dependent
- FU 4-6 mo postpartum, post delivery
- regress rapidly after you stop lactation
LMO done in ?
kyphosis/pectus exca
central line, pacemaker
NO BR-3 if ?
palablae
new/growing
on SG MG
shape on US, MG, MR?
Round
oval
irregular
MR margin
IRREGULAR
spiculated
circusm
enlarging Lipoma Mx?
Bx
PASH MX
FU annually
phylliod tum ca risk
10% >> degenration large > 3 cm might harbour IDC, DCIS, ILC or sarcoma. mets > lung hematogenous Rx: Sx with wide margin > 2 cm. high rate of recurrance if < 2 cm. no CTx ot RTx FU every 6 month?3yr
Round IDC DDx
mucinous
medullary ( +calc, might have + Ax LAD, lymphiod infiltration on path, BRCA1)
ILC
dark starolder pt > IDC US: shadowing w/o a mass washout is less common than IDC Ax mets less common 1/5 missed on MG 1/3 b/l
MQSA physician req
240/6 mo/ last 2yr
960/24 mo
8 CME new
15 CME/36 mo
MG facility inspected by FDA each.
eval their physicians compliance
year
BRCA1
ADD
CH. 17 tumor supressor gene
life time risk of BCA: 50-85%
MG paddle
- 18X24, 24X30 cm.
- 25-45 Ib.
- collimate to detector not br contour.
ab interpretation rate = recall rate
no. of BR 0, 4,5/ total SG MG
only count SG
DG interpretation rate
BR 4,5 on DG/ total DG
cancer detection rate?
+ve Bx/ total SG
PEG direction on MRI
Ax: LT > RT
Sag: Sup > inf
DAILY QC for screen film
darkroom cleaniness
processor QC
Weekly QC?
screen cleanliness
phantom
viewbox cleanliness
Montly?
Visual checklist
Quarterly
repeat analysis
analysis of fixer retention
Semi-annually
darkroom fog
screen-film contact
compression
ghost artifact on MG 2/2
low temp dtector»_space; warm it up
readout failure artifact 2/2
software failure.
GAD Dose use in MRI Br
0.1 mmol/kg
detector interface line on MG
2/2 Se based detector. slight differ in caliber of two halves of the detector
SG MG
cancer detection ra te > 2.5 recall rate: 5-12% PPV1: 3-8% PPV: 20-40% Sn > 75% Sp 88-95%
malg risk in calc
coarse hetro: 13%
amorph: 21%
fine pleo 29%
fine branching > 80%
HER2 +ve Px
more aggressive vs HER2 negative»_space; rapid growth and spread
20% of BCA
less responsive to hormonal Rx.
MCL of BCA in male
subarloar ( only 1% in F)
Interval ca?
cancer detected between SG MG.
lobular or mucinous
male w/ palable mass < 30 ?
US
MBI
whole body radiation
Br density does not matter Sn for all
During active phase: b/l patchy GH tX uptake is expected
B/l Br edema
LAD SVC obstruction Psoriasis Scleroderma Dermatocytitis
Poland synd ass cn?
Lung
bCA
Lymphoma leukemia
ARD
CI to B RTx
Preg
Hx of Rad
Multi centric or diffuse disease
CVD
Focal fibrosis in Post-M
HRT
Usually seen in pre-M
When post Sx or RTx C+ subsides ?
String until 9 No
Starts to subside 10-18 months
Very low more than 24 mo
Milk fistula risk w/ percut Bx?
Low
Higher with Sx Bx
Start w/ percut one. Should not preclude you from Bx high risk lesion
Percentage of Contralateral detected BR cancer ?in MR
3-5%
MBI
Small FOV
Rad dose higher than MG
Not affected by density
Cysts in men
Men don’t undergo lobular development so no B9 FCC
Concerning finding
Round lesion in US BIRAD?
4
3» oval
Fetal dose from SG MG is
<50 mGy
Risk of organ mal and mental retardation > 100mGy if done 3-8 wk
MC mets to BR
1st: BCA
2nd: Melanoma
RF of gynecomastia
Liver failure thyriod dis ( high and low) meds: TCA, pred hypogonadism testicular failure mump KF COPD DM
Uni: 45%
PASH growing next?
excitional Bx because risk of low grade angiosarcoma. they look alike
ADH upgrade rate?
1 in5
11-50%
Inflam BCA
!% only
skin thickening
T4
Intraductal pap MX
Consevative
if atypical or atypia detected»_space; Sx excitional Bx
compression?
- decreased dynamic range
- decreased dose
- increased resolution, contrast.
- decreased
is ASA or AC safe with breast Bx?
yes
not for colipdegrol
MC compl of Br Sx
seroma
absolute CI of breast conservative Rx ( lump + RTx)
1st, 2nd tri preg
Hx of RTx
multicentric diz or diffuse malg calc
positive margin despite wide resection
relative CI of breast conservative Sx
CVD
poor cosomtic outcome.
next step if there is imaging-histo discordance follwoing stero or MR Bx>
SX
dont repeat stearo or MR Bx
Max lidocaine dose w/ epi?
7mg/kg, not > 500 mg total
ratio: 1:100,000
Max lido w/o epi?
4.5 mg/kg, not > 300 mg total
T/F ALH has to get Sx Bx ?
FALSE
compl of percutanous US guided Bx includes?
pseudoaneyrsm
ghalactography dose ?
0.2-0.3 ml, dont exceed 1.0 ml
30 G needle
if the pore duct is not identified >> dont do it
only for single, Unilat, spontanous duct.
only bloody, serous, or yellow discharge.
WHITE or GREEN discahrge»_space;» B9
if there is ab»_space; loc w/ Bx marker or wire during ductoram, not straightforward to sX
DOnt Bx based on stero, you cant see the ab
superficial tx lido buffered with NaHCO4 w/ ratio of?
1:9
flat epitheleal atypia upgrade rate?
1/3 to high risk lesion or DCIS OR IDC
ICL FN rate?
21%
Electronic mag results in ?
Same dose and SR
But more noise
Vs geometric mag
MBI detector
Cadmium zinc tellirude